Medicare Rx Payment Method Deters Hospital Use Of High-Cost Drugs – BIO

Basing Medicare reimbursement for hospital-administered drugs on a single cost-to-charge ratio will lead hospitals to stop providing higher cost drugs and biological products, Alkermes CEO Richard Pops told the Senate Appropriations/HHS Subcommittee Jan. 30

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet